相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Real-time measurement of adenosine and ATP release in the central nervous system
Nicholas Dale
PURINERGIC SIGNALLING (2021)
P2X7 is a cytotoxic receptor horizontal ellipsis .maybe not: implications for cancer
Francesco Di Virgilio
PURINERGIC SIGNALLING (2021)
Nociceptive signaling of P2X receptors in chronic pain states
Kazuhide Inoue
PURINERGIC SIGNALLING (2021)
Geoffery Burnstock's influence on the evolution of P2X3 receptor pharmacology
Michael F. Jarvis
PURINERGIC SIGNALLING (2021)
Update of P2X receptor properties and their pharmacology: IUPHAR Review 30
Peter Illes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Ectonucleoside triphosphate diphosphohydrolases and ecto-5′-nucleotidase in purinergic signaling: how the field developed and where we are now
Herbert Zimmermann
PURINERGIC SIGNALLING (2021)
Purinergic signalling in spinal pain processing
Theresa H. Tam et al.
PURINERGIC SIGNALLING (2021)
Update of P2Y Receptor Pharmacology: IUPHAR Review:27
Kenneth A. Jacobson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
Romain Lara et al.
FRONTIERS IN PHARMACOLOGY (2020)
Gefapixant in two randomised dose-escalation studies in chronic cough
Jaclyn A. Smith et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Characterisation of P2Y2 receptors in human vascular endothelial cells using AR-C118925XX, a competitive and selective P2Y2 antagonist
Markie O. Muoboghare et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications
Gabriella Marucci et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Tools and drugs for uracil nucleotide-activated P2Y receptors
Muhammad Rafehi et al.
PHARMACOLOGY & THERAPEUTICS (2018)
A phase I clinical trial demonstrates that nfP2X7-targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma
S. M. Gilbert et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation
Welbeck Danquah et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Structural basis for subtype-specific inhibition of the P2X7 receptor
Akira Karasawa et al.
ELIFE (2016)
ATP as a cotransmitter in the autonomic nervous system
Charles Kennedy
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2015)
Two disparate ligand-binding sites in the human P2Y1 receptor
Dandan Zhang et al.
NATURE (2015)
Agonist-bound structure of the human P2Y12 receptor
Jin Zhang et al.
NATURE (2014)
Structure of the human P2Y12 receptor in complex with an antithrombotic drug
Kaihua Zhang et al.
NATURE (2014)
A Selective High-Affinity Antagonist of the P2Y14 Receptor Inhibits UDP-Glucose-Stimulated Chemotaxis of Human Neutrophils
Matthew O. Barrett et al.
MOLECULAR PHARMACOLOGY (2013)
Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors
W. Noerenberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Molecular mechanism of ATP binding and ion channel activation in P2X receptors
Motoyuki Hattori et al.
NATURE (2012)
NF546 [4,4 '-(Carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha '-diphosphonic Acid) Tetrasodium Salt] Is a Non-Nucleotide P2Y(11) Agonist and Stimulates Release of Interleukin-8 from Human Monocyte-Derived Dendritic Cells
Sabine Meis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Identification of atropine- and P2X1 receptor antagonist-resistant, neurogenic contractions of the urinary bladder
Charles Kennedy et al.
JOURNAL OF NEUROSCIENCE (2007)
International union of pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy
Maria P. Abbracchio et al.
PHARMACOLOGICAL REVIEWS (2006)
Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor
YC Kim et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Diisothiocyanate derivatives as potent, insurmountable antagonists of P2y6 nucleotide receptors
LK Mamedova et al.
BIOCHEMICAL PHARMACOLOGY (2004)